Abstract
β-Cyclodextrin/ibuprofen inclusion complex was synthesized by freeze-drying method and characterized for phase solubility profiles, infrared spectra, thermal analysis, and X-ray powder diffractograms. The inclusion complex with HP-β-CD, as confirmed by molecular dynamics simulations, enhanced the aqueous solubility of ibuprofen by almost 30-fold compared to ibuprofen alone. Different grades of Carbopol (Carbopol 934P/Carbopol 974P/Carbopol 980 NF/Carbopol Ultrez 10 NF) and cellulose derivatives (HPMC K100M/HPMC K15M/HPMC K4M/HPMC E15LV/HPC) were evaluated for mucoadhesive gels incorporating the inclusion complex. The central composite design generated by Design-Expert was employed to optimize the mucoadhesive gel using two independent variables (a varying combination of two gelling agents) on three dependent variables (drug content and in vitro drug release at 6 h and 12 h). Except for the methylcellulose-based gels, most of the gels (0.5%, 0.75%, and 1% alone or as a mixture thereof) exhibited an extended-release of ibuprofen, ranging from 40 to 74% over 24 h and followed the Korsmeyer-Peppas kinetics model. Using this test design, 0.95% Carbopol 934P and 0.55% HPC-L formulations were optimized to increase ibuprofen release, enhance mucoadhesion, and be non-irritating in ex vivo chorioallantoic membrane studies. The present study successfully developed a mucoadhesive gel containing the ibuprofen-β-cyclodextrin inclusion complex with sustained release.
Graphical Abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1208%2Fs12249-023-02534-7/MediaObjects/12249_2023_2534_Fig8_HTML.png)
Similar content being viewed by others
Data Availability
Data will be made available on request.
References
Ghosh S, Roy G, Mukherjee B. Dental mold: a novel formulation to treat common dental disorders. AAPS PharmSciTech. 2009;10(2):692–702. https://doi.org/10.1208/s12249-009-9255-9.
Orlando BJ, Lucido MJ, Malkowski MG. The structure of ibuprofen bound to cyclooxygenase-2. J Struct Biol. 2015;189(1):62–6. https://doi.org/10.1016/j.jsb.2014.11.005.
Pozzi A, Gallelli L. Pain management for dentists: the role of ibuprofen. Ann Stomatol (Roma). 2011;2(3–4 Suppl):3–24.
Cooper SA. The relative efficacy of ibuprofen in dental pain. Compend Contin Educ Dent. 1986;7(8):578, 80–1, 84–8 passim.
Álvarez C, Núñez I, Torrado JJ, Gordon J, Potthast H, García-Arieta A. Investigation on the Possibility of biowaivers for ibuprofen. J Pharm Sci. 2011;100(6):2343–9. https://doi.org/10.1002/jps.22472.
Drini M. Peptic ulcer disease and non-steroidal anti-inflammatory drugs. Aust Prescr. 2017;40(3):91–3. https://doi.org/10.18773/austprescr.2017.037.
Narayanaswamy R, Torchilin VP. Hydrogels and their applications in targeted drug delivery. Molecules. 2019;24(3). https://doi.org/10.3390/molecules24030603.
Czyrski A. Determination of the Lipophilicity of ibuprofen, naproxen, ketoprofen, and flurbiprofen with thin-layer chromatography. J Chem. 2019;2019:3407091. https://doi.org/10.1155/2019/3407091.
Carneiro SB, Costa Duarte FÍ, Heimfarth L, Siqueira Quintans JdS, Quintans-Júnior LJ, Veiga Júnior VFd, et al. Cyclodextrin-drug inclusion complexes: in vivo and in vitro approaches. Int J Mol Sci. 2019;20(3):642. https://doi.org/10.3390/ijms20030642.
Connors KA. The stability of cyclodextrin complexes in solution. Chem Rev. 1997;97(5):1325–58. https://doi.org/10.1021/cr960371r.
Chen C-Y, Chen F-A, Wu A-B, Hsu H-C, Kang J-J, Cheng H-W. Effect of hydroxypropyl-β-cyclodextrin on the solubility, photostability and in-vitro permeability of alkannin/shikonin enantiomers. Int J Pharm. 1996;141(1):171–8. https://doi.org/10.1016/0378-5173(96)04634-0.
Tommasini S, Calabrò ML, Raneri D, Ficarra P, Ficarra R. Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin. J Pharm Biomed Anal. 2004;36(2):327–33. https://doi.org/10.1016/j.jpba.2004.06.013.
Hładoń T, Pawlaczyk J, Szafran; B. Stability of ibuprofen in its inclusion complex with β-cyclodextrin. J Incl Phenom Macrocycl Chem. 2000;36(1):1–3. https://doi.org/10.1023/A:1008046724527.
Motoyama K, Nagatomo K, AbdElazim SO, Hirayama F, Uekama K, Arima H. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug. Chem Pharm Bull (Tokyo). 2009;57(11):1206–12. https://doi.org/10.1248/cpb.57.1206.
Woldum HS, Larsen KL, Madsen F. Cyclodextrin controlled release of poorly water-soluble drugs from hydrogels. Drug Deliv. 2008;15(1):69–80. https://doi.org/10.1080/10717540701829267.
Ai F, Wang J, Li Y, Ma Y. Effect of drug particle size on complexation, physicochemical properties and dissolution of cyclodextrin inclusion complexes. Indian J Pharm Sci. 2017;79(1):131–8. https://doi.org/10.4172/pharmaceutical-sciences.1000209.
Conceição J, Adeoye O, Cabral-Marques HM, Lobo JMS. Cyclodextrins as excipients in tablet formulations. Drug Discov Today. 2018;23(6):1274–84. https://doi.org/10.1016/j.drudis.2018.04.009.
Marques HMC. A review on cyclodextrin encapsulation of essential oils and volatiles. Flavour Fragr J. 2010;25(5):313–26. https://doi.org/10.1002/ffj.2019.
Gould S, Scott RC. 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review. Food Chem Toxicol. 2005;43(10):1451–9. https://doi.org/10.1016/j.fct.2005.03.007.
Sherje A, Londhe V. Inclusion complexes of hydroxy propyl-β-cyclodextrin and paliperidone: preparation and characterization. Curr Drug Discov Technol. 2014;11(4):271–8. https://doi.org/10.2174/1570163812666150109103618.
Creteanu A, Pamfil D, Vasile C, Tantaru G, Ghiciuc CM, Ochiuz L, et al. Study on the role of the inclusion complexes with 2-hydroxypropyl-<i>β</i>-cyclodextrin for oral administration of amiodarone. International Journal of Polymer Science. 2019;2019:1695189. https://doi.org/10.1155/2019/1695189.
Higuchi T, Connors KA. Phase solubility techniques. In: Reilly CN, editor. Advances in Analytical Chemistry Instrumentation, vol. 4. New York, NY: Interscience; 1965. p. 117–212.
Li N, Wang N, Wu T, Qiu C, Wang X, Jiang S, et al. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Drug Dev Ind Pharm. 2018;44(12):1966–74. https://doi.org/10.1080/03639045.2018.1505904.
Sravya, Maddukuri, Deveswaran, Rajamanickam, Bharath, Srinivasan, et al. Development of orodispersible tablets of candesartan cilexetil-B-cyclodextrin complex. J Pharm. 2013:13. https://doi.org/10.1155/2013/583536.
Patel P , Pol A, More S, Kalia; DKY, Patravale V. Colloidal soft nanocarrier for transdermal delivery of dopamine agonist: ex vivo and in vivo evaluation. J Biomed Nanotechnol. 2014;10:13.
Patel PA, Patil SC, Kalaria DR, Kalia YN, Patravale VB. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A. Int J Pharm. 2013;446(1):16–23. https://doi.org/10.1016/j.ijpharm.2013.02.014.
Srivastava M, Kohli K, Ali M. Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis. Drug Deliv. 2016;23(1):154–66. https://doi.org/10.3109/10717544.2014.907842.
Chen X, Yan J, Yu S, Wang P. Formulation and in vitro release kinetics of mucoadhesive blend gels containing matrine for buccal administration. AAPS PharmSciTech. 2018;19(1):470–80. https://doi.org/10.1208/s12249-017-0853-7.
Pereira Camelo SR, Franceschi S, Perez E, Girod Fullana S, Ré MI. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug. Drug Dev Ind Pharm. 2016;42(6):985–97. https://doi.org/10.3109/03639045.2015.1103746.
Da-Lozzo EJ, Moledo RC, Faraco CD, Ortolani-Machado CF, Bresolin TM, Silveira JL. Curcumin/xanthan-galactomannan hydrogels: rheological analysis and biocompatibility. Carbohydr Polym. 2013;93(1):279–84. https://doi.org/10.1016/j.carbpol.2012.02.036.
Vinardell MP, Mitjans M. The chorioallantoic membrane test as a model to predict the potential human eye irritation induced by commonly used laboratory solvents. Toxicol In Vitro. 2006;20(6):1066–70. https://doi.org/10.1016/j.tiv.2005.11.004.
Campbell CT, Sellers JRV. Enthalpies and entropies of adsorption on well-defined oxide surfaces: experimental measurements. Chem Rev. 2013;113(6):4106–35. https://doi.org/10.1021/cr300329s.
Fang Y, Lakey PSJ, Riahi S, McDonald AT, Shrestha M, Tobias DJ, et al. A molecular picture of surface interactions of organic compounds on prevalent indoor surfaces: limonene adsorption on SiO2. Chem Sci. 2019;10(10):2906–14. https://doi.org/10.1039/C8SC05560B.
Swenson H, Stadie NP. Langmuir’s theory of adsorption: a centennial review. Langmuir. 2019;35(16):5409–26. https://doi.org/10.1021/acs.langmuir.9b00154.
Maheshwari P, Gorgol M, Kierys A, Zaleski R. Positron probing of liquid-free volume to investigate adsorption–desorption behavior of water in two-dimensional mesoporous SBA-3. J Phys Chem C. 2017;121(32):17251–62. https://doi.org/10.1021/acs.jpcc.7b04317.
Arora SC, Sharma PK, Irchhaiya R, Khatkar A, Singh N, Gagoria J. Development, characterization and solubility study of solid dispersions of Cefuroxime Axetil by the solvent evaporation method. J Adv Pharm Technol Res. 2010;1(3):326–9. https://doi.org/10.4103/0110-5558.72427.
Ribeiro A, Figueiras A, Santos D, Veiga F. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin. AAPS PharmSciTech. 2008;9(4):1102–9. https://doi.org/10.1208/s12249-008-9143-8.
Aleem O, Kuchekar B, Pore Y, Late S. Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. J Pharm Biomed Anal. 2008;47(3):535–40. https://doi.org/10.1016/j.jpba.2008.02.006.
Pinto MF, de Moura EA, de Souza FS, Macêdo RO. Thermal compatibility studies of nitroimidazoles and excipients. J Therm Anal Calorim. 2010;102(1):323–9. https://doi.org/10.1007/s10973-010-0889-3.
de Mendonça CMS, de Barros Lima IP, Aragão CFS, Gomes APB. Thermal compatibility between hydroquinone and retinoic acid in pharmaceutical formulations. J Therm Anal Calorim. 2014;115(3):2277–85. https://doi.org/10.1007/s10973-013-2941-6.
Wahab A, Khan GM, Akhlaq M, Khan N, Hussain A. Pre-formulation investigation and in vitro evaluation of directly compressed ibuprofen-ethocel oral controlled release matrix tablets: a kinetic approach. Afr J Pharm Pharmacol. 2011;5:2118–27. https://doi.org/10.5897/AJPP11.128.
Onischuk A, Tolstikova T, Sorokina I, Zhukova N, Baklanov A, Karasev V, et al. Analgesic effect from ibuprofen nanoparticles inhaled by male mice. J Aerosol Med Pulm Drug Deliv. 2009;22:245–53. https://doi.org/10.1089/jamp.2008.0721.
Loh GOK, Tan YTF, Peh K-K. Enhancement of norfloxacin solubility via inclusion complexation with β-cyclodextrin and its derivative hydroxypropyl-β-cyclodextrin. Asian J Pharm Sci. 2016;11(4):536–46. https://doi.org/10.1016/j.ajps.2016.02.009.
Yadav VR, Suresh S, Devi K, Yadav S. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech. 2009;10(3):752–62. https://doi.org/10.1208/s12249-009-9264-8.
Lubrizol. Carbopol® polymer products. 2020 [cited 2020 29 March]; Available from: https://www.lubrizol.com/Health/Pharmaceuticals/Excipients/Carbopol-Polymer-Products. Accessed 20 March 2023.
Varges P, Costa C, Fonseca B, Naccache M, De Souza MP. Rheological characterization of Carbopol® dispersions in water and in water/glycerol solutions. Fluids. 2019;4:3. https://doi.org/10.3390/fluids4010003.
Aslani A, Malekpour N. Design, formulation, and physicochemical evaluation of periodontal propolis mucoadhesive gel. Dent Res J (Isfahan). 2016;13(6):484–93. https://doi.org/10.4103/1735-3327.197037.
Jelvehgari M, Rashidi M-R, Samadi H. Mucoadhesive and drug release properties of benzocaine gel. Iran J Pharm Sci Autumn. 2006;2:185–94.
Lefnaoui S, Moulai-Mostefa N. Investigation and optimization of formulation factors of a hydrogel network based on kappa carrageenan–pregelatinized starch blend using an experimental design. Colloids Surf, A. 2014;458:117–25. https://doi.org/10.1016/j.colsurfa.2014.01.007.
Baishya H, Yangxing Z. The influence of HPMC viscosity and %HPC content as FRC parameter on the release of highly soluble drug from hydrophilic matrix tablets. J Pharm Drug Deliv Res. 2016;05. https://doi.org/10.4172/2325-9604.1000155.
https://www.nippon-soda.co.jp/hpc-e/care_stable.php. [cited 2020 23 Dec 2020]. Accessed 20 March 2023.
Vueba ML, Batista de Carvalho LAE, Veiga F, Sousa JJ, Pina ME. Influence of cellulose ether mixtures on ibuprofen release: MC25, HPC and HPMC K100M. Pharm Dev Technol. 2006;11(2):213–28. https://doi.org/10.1080/10837450600561349.
Bhowmik M, Bain MK, Ghosh LK, Chattopadhyay D. Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels. Pharm Dev Technol. 2011;16(4):385–91. https://doi.org/10.3109/10837451003774369.
Raval M, Bagada H. Formulation and evaluation of cyclodextrin-based thermosensitive in situ gel of azithromycin for periodontal delivery. J Pharm Innov. 2019. https://doi.org/10.1007/s12247-019-09422-3.
Baliga S, Muglikar S, Kale R. Salivary pH: a diagnostic biomarker. J Indian Soc Periodontol. 2013;17(4):461–5. https://doi.org/10.4103/0972-124X.118317.
Labib GS, Farid RM. Osteogenic effect of locally applied Pentoxyfilline gel: in vitro and in vivo evaluations. Drug Deliv. 2015;22(8):1094–102. https://doi.org/10.3109/10717544.2014.884193.
Acknowledgements
The authors would also like to thank IOL Chemicals and Pharmaceuticals Limited, Ludhiana, India, for ibuprofen, Lubrizol Corporation, USA, for different grades of carbopols and Colorcon Asia Pvt. Limited, India, for different grades of HPMC. Authors are thankful to B.N. University, Udaipur, Rajasthan, for providing necessary financial support.
Author information
Authors and Affiliations
Contributions
Methodology, experiments, writing (original draft), CU; editing and review, PP, AD, and KKU; in silico work, VV; writing review, editing, and supervision, Meenakshi Bharkatiya.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Upadhyay, C., D’Souza, A., Patel, P. et al. Inclusion Complex of Ibuprofen-β-Cyclodextrin Incorporated in Gel for Mucosal Delivery: Optimization Using an Experimental Design. AAPS PharmSciTech 24, 100 (2023). https://doi.org/10.1208/s12249-023-02534-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-023-02534-7